A Comparative Evaluation of Mediastinal Nodal SUVmax and Derived Ratios from 18 F-FDG PET/CT Imaging to Predict Nodal Metastases in Non-Small Cell Lung Cancer.
Maha AlRasheediSai HanHelene ThygesenMatt NeilsonFraser HendryAhmed AlkarnJohn D MaclayHing Y LeungPublished in: Diagnostics (Basel, Switzerland) (2023)
18 F-FDG positron emission tomography with computed tomography (PET/CT) is a standard imaging modality for the nodal staging of non-small cell lung cancer (NSCLC). To improve the accuracy of pre-operative staging, we compare the staging accuracy of mediastinal lymph node (LN) standard uptake values (SUV) with four derived SUV ratios based on the SUV values of primary tumours (TR), the mediastinal blood pool (MR), liver (LR), and nodal size (SR). In 2015-2017, 53 patients (29 women and 24 men, mean age 67.4 years, range 53-87) receiving surgical resection have pre-operative evidence of mediastinal nodal involvement (cN2). Among these, 114 mediastinal nodes are resected and available for correlative PET/CT analysis. cN2 status accuracy is low, with only 32.5% of the cN2 cases confirmed pathologically. Using receiver operating characteristic (ROC) curve analyses, a SUVmax of N2 LN performs well in predicting the presence of N2 disease (AUC, 0.822). Based on the respective selected thresholds for each ROC curve, normalisation of LN SUVmax to that for mediastinum, liver and tumour improved sensitivities of LN SUVmax from 68% to 81.1-89.2% while maintaining acceptable specificity (68-70.1%). In conclusion, normalised SUV ratios (particularly LR) improve current pre-operative staging performance in detecting mediastinal nodal involvement.
Keyphrases
- lymph node
- pet ct
- positron emission tomography
- computed tomography
- sentinel lymph node
- neoadjuvant chemotherapy
- lymph node metastasis
- end stage renal disease
- pet imaging
- chronic kidney disease
- small cell lung cancer
- metabolic syndrome
- magnetic resonance imaging
- polycystic ovary syndrome
- radiation therapy
- patient reported outcomes
- pregnant women
- contrast enhanced
- peritoneal dialysis
- advanced non small cell lung cancer
- magnetic resonance
- ultrasound guided